Female Genital Schistosomiasis Lesion Resolution Post-Treatment with Praziquantel in Zambian Adults
- PMID: 38190749
- PMCID: PMC10859808
- DOI: 10.4269/ajtmh.23-0552
Female Genital Schistosomiasis Lesion Resolution Post-Treatment with Praziquantel in Zambian Adults
Abstract
We evaluated changes in female genital schistosomiasis (FGS) 6 to 12 months after praziquantel treatment among 43 adult Zambian women. Most women (60%) experienced decreased FGS severity and 23% experienced complete lesion resolution. This is the first study to demonstrate a meaningful effect of praziquantel treatment of FGS in adult women.
Conflict of interest statement
Disclosure: This study was approved by the Institutional Review Board of Emory University (IRB00071160) and the Research Ethics Committee of the University of Zambia (011-10-14). Participants completed written informed consent. This activity was reviewed by the CDC and was conducted consistent with applicable federal law and CDC policy. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the CDC.
Figures
References
-
- UNAIDS , 2019. No More Neglect: Female Genital Schistosomiasis and HIV. Available at: https://www.unaids.org/sites/default/files/media_asset/female_genital_sc.... Accessed June 28, 2023.
-
- Bustinduy AL, Randriansolo B, Sturt AS, Kayuni SA, Leustcher PDC, Webster BL, Van Lieshout L, Stothard JR, Feldmeier H, Gyapong M, 2022. An update on female and male genital schistosomiasis and a call to integrate efforts to escalate diagnosis, treatment and awareness in endemic and non-endemic settings: the time is now. Adv Parasitol 115: 1–44. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
